exRNAdisease

Entry Detail

---



General Information

Database ID: exR0269389 RNA Name: hsa-miR-140-5p RNA Type: miRNA Chromosome: chr16 Starnd: + Coordinate: Start Site(bp): 69933103 End Site(bp): 69933124 External Links: hsa-miR-140-5p

Disease Information

Disease Name: Multiple Sclerosis Disease Category: Nervous System Diseases MeSH ID: D009103 Type: Diseases Category/Nervous System Diseases Alias: Sclerosis, Multiple//Sclerosis, Disseminated//Disseminated Sclerosis//MS (Multiple Sclerosis)//Multiple Sclerosis, Acute Fulminating

Expression Detail

GEO ID: GSE140106 Description: Serum exosome microRNAs predict multiple sclerosis disease activity after fingolimod treatment Experimental Design: Fingolimod treatment Case Disease Type: Multiple Sclerosis Case Disease SubType: NA Case Sample: Fingolimod treated Multiple Sclerosis Control Sample: Untreated Number of Case: 27 Number of Control: 27 Number of Samples: 54

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand ARIH1 chr15 72474330 72602987 + BTBD7 chr14 93237550 93333092 - C15orf41 chr15 36579626 36810248 + CLPTM1 chr19 44954585 44993341 + COL4A2 chr13 110305812 110513209 + ITPRIPL2 chr16 19113932 19121629 + NME4 chr16 396725 410367 + POLR3G chr5 90471748 90514557 + SCRN1 chr7 29920104 29990289 - SLC6A6 chr3 14402576 14489349 + SRP14 chr15 40035690 40039181 - TMEM181 chr6 158536436 158635428 + TNRC6B chr22 40044817 40335808 + TRIO chr5 14143342 14532128 + ZNF800 chr7 127346790 127431924 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000712 chr16 68208276 68225678 + hsa_circ_0001699 chr7 40027197 40041630 + hsa_circ_0001472 chr5 36953719 36976504 + hsa_circ_0000032 chr1 25666964 25669564 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AL162258.1 chr1 153626332 153634340 - DHRS4-AS1 chr14 23938219 24052555 - H19 chr11 1995176 2001470 - KCNQ1OT1 chr11 2608328 2699994 - MALAT1 chr11 65497688 65506516 + NEAT1 chr11 65422774 65445540 + SNHG1 chr11 62851984 62855953 - SNHG16 chr17 76557764 76565348 + SNHG20 chr17 77086716 77099902 + TDRKH-AS1 chr1 151790804 151794402 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE140106 Sample Source: Blood Source Fraction: Exosome Platform: GPL11154 Method: NGS Num of detected RNA Type: 1 Num of detected RNAs of this Type: 1907 Sample treatment protocol: Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). RNA Extract protocol: Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer's protocol. RNA library preparation protocol: Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer's instructions.

Reference

PMID: 31721043 Title: Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment Author: Ebrahimkhani S, Beadnall HN, Wang C, Suter CM, Barnett MH, Buckland ME, Vafaee F Journal: Mol Neurobiol. 2020 Feb;57(2):1245-1258. Description: we sought the possible utility of serum exosome microRNAs as biomarkers for disease activity in multiple sclerosis patients in response to fingolimod therapy.